Price T Rowe Associates Inc. MD Has $1.03 Billion Stake in HCA Healthcare, Inc. (NYSE:HCA)

Price T Rowe Associates Inc. MD decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,101,049 shares of the company’s stock after selling 214,416 shares during the quarter. Price T Rowe Associates Inc. MD owned about 1.18% of HCA Healthcare worth $1,034,294,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of HCA. Pacer Advisors Inc. boosted its stake in HCA Healthcare by 8.4% during the 4th quarter. Pacer Advisors Inc. now owns 15,488 shares of the company’s stock worth $4,192,000 after acquiring an additional 1,205 shares during the last quarter. Ritholtz Wealth Management increased its holdings in HCA Healthcare by 24.9% during the fourth quarter. Ritholtz Wealth Management now owns 8,012 shares of the company’s stock worth $2,169,000 after buying an additional 1,596 shares during the last quarter. Inscription Capital LLC grew its position in shares of HCA Healthcare by 12.9% in the 4th quarter. Inscription Capital LLC now owns 3,445 shares of the company’s stock valued at $932,000 after acquiring an additional 394 shares during the period. Global Retirement Partners LLC grew its position in HCA Healthcare by 62.3% during the fourth quarter. Global Retirement Partners LLC now owns 10,810 shares of the company’s stock worth $3,036,000 after buying an additional 4,150 shares in the last quarter. Finally, Woodmont Investment Counsel LLC grew its position in HCA Healthcare by 2.1% during the fourth quarter. Woodmont Investment Counsel LLC now owns 60,742 shares of the company’s stock worth $16,442,000 after buying an additional 1,250 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.6 %

NYSE:HCA traded up $1.99 during trading hours on Friday, hitting $354.78. 1,215,941 shares of the company were exchanged, compared to its average volume of 1,679,664. The stock has a market capitalization of $92.92 billion, a price-to-earnings ratio of 17.69, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 1.02 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $356.30. The company has a fifty day simple moving average of $330.12 and a 200 day simple moving average of $323.11.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same period last year, the company posted $4.29 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. Sell-side analysts expect that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now directly owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last three months. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday. Truist Financial raised their target price on HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. TD Cowen reduced their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Finally, SVB Leerink raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $339.72.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.